Valuation : Integra LifeSciences Holdings Corporation

Market Cap 1.31B 1.13B 1.06B 971M 1.83B 125B 1.83B 12.6B 4.92B 63.35B 4.93B 4.82B 210B P/E 2026 *
26.4x
P/E 2027 * 13.6x
Enterprise Value 2.8B 2.42B 2.27B 2.07B 3.9B 267B 3.92B 26.89B 10.5B 135B 10.52B 10.29B 449B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.5x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+0.24%
1 week+1.81%
Current month+1.44%
1 month-13.52%
3 months+11.19%
6 months+48.42%
Current year+35.99%
1 week 16.39
Extreme 16.39
17.33
1 month 16.04
Extreme 16.04
19
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2026
Director of Finance/CFO 54 27/06/2023
Chief Tech/Sci/R&D Officer - 16/02/2026
Director TitleAgeSince
Chairman 64 02/01/2012
Director/Board Member 81 31/12/1991
Director/Board Member 65 31/12/2005
Date Insider Type Main position Quantity % Market Cap.
03/07/26 Tax

Chief Financial Officer

-5,226 0.0067%
01/07/26 Free

Executive/Senior Manager

5,590 0.0072%
01/07/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+1.81%+13.58%-59.39% 1.31B
+0.79%-1.46%-14.45%+7.93% 193B
+1.40%-1.16%-0.89%+11.00% 115B
+0.25%+2.33%+10.83%+79.42% 61.3B
-0.25%-3.31%+27.04%+55.45% 51.37B
+0.74%+1.01%-3.01%-32.32% 51.24B
+1.71%+0.67%+18.91%-9.87% 33.69B
+1.82%+8.29% - - 30.4B
-2.49%-4.61%+37.20%-14.29% 24.36B
-0.82%-1.46%-5.14%+22.13% 23.7B
Average +0.10%-0.00%+9.34%+6.67% 58.56B
Weighted average by Cap. +0.04%-1.04%+0.80%+15.53%

Financials

2026 *2027 *
Net sales 1.67B 1.45B 1.36B 1.24B 2.33B 160B 2.34B 16.06B 6.27B 80.76B 6.29B 6.15B 268B 1.73B 1.49B 1.4B 1.28B 2.4B 165B 2.41B 16.58B 6.47B 83.34B 6.49B 6.35B 277B
Net income 42.03M 36.29M 34.02M 31.06M 58.43M 4.01B 58.71M 403M 157M 2.03B 158M 154M 6.73B 78.69M 67.94M 63.69M 58.14M 109M 7.5B 110M 755M 295M 3.8B 295M 289M 12.59B
Net Debt 1.49B 1.29B 1.21B 1.1B 2.07B 142B 2.08B 14.29B 5.58B 71.83B 5.59B 5.47B 238B 1.28B 1.11B 1.04B 949M 1.79B 123B 1.79B 12.33B 4.81B 61.97B 4.82B 4.72B 206B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
28/08/26 US$16.89 +0.24% 776,237
27/08/26 US$16.85 -0.18% 449,758
26/08/26 US$16.88 +0.54% 489,357
25/08/26 US$16.79 +0.60% 369,535
24/08/26 US$16.69 -0.30% 654,658
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
16.89USD
Average target price
19.56USD
Spread / Average Target
+15.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock